Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Viemed Healthcare, Inc. (VMD : NSDQ)

• Company Description    Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. Number of Employees: 1,382

• Price / Volume Information    Yesterday's Closing Price: $8.85 Daily Weekly Monthly 20 Day Moving Average: 457,111 shares Shares Outstanding: 38.09 (millions) Market Capitalization: $337.08 (millions) Beta: 1.10 52 Week High: $12.61 52 Week Low: $6.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.16% -26.79% 12 Week -11.59% -12.86% Year To Date 19.11% 3.33%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 625 East Kaliste Saloom Road - Lafayette,LA 70508 USA ph: 337-504-3802 fax: - glen@bristolir.com http://www.viemed.com

• General Corporate Information    Officers Casey Hoyt - Chief Executive Officer Randy Dobbs - Chairman W. Todd Zehnder - Chief Operating Officer Trae Fitzgerald - Chief Financial Officer Sabrina Heltz - Director Peer Information Viemed Healthcare, Inc. (BJCT) Viemed Healthcare, Inc. (CADMQ) Viemed Healthcare, Inc. (APNO) Viemed Healthcare, Inc. (UPDC) Viemed Healthcare, Inc. (IMTIQ) Viemed Healthcare, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92663R105 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 38.09 Most Recent Split Date: (:1) Beta: 1.10 Market Capitalization: $337.08 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.42 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: 21.07 Trailing 12 Months: 24.58 PEG Ratio: - Price Ratios Price/Book: 2.31 Price/Cash Flow: 7.69 Price / Sales: 1.12 EPS Growth vs. Year Ago Period: -12.50% vs. Previous Quarter: 16.67% Sales Growth vs. Year Ago Period: 23.85% vs. Previous Quarter: 3.56% ROE 06/30/26 - 10.16 03/31/26 - 10.52 12/31/25 - 10.72 ROA 06/30/26 - 7.22 03/31/26 - 7.60 12/31/25 - 7.82 Current Ratio 06/30/26 - 1.13 03/31/26 - 1.22 12/31/25 - 1.18 Quick Ratio 06/30/26 - 1.02 03/31/26 - 1.10 12/31/25 - 1.06 Operating Margin 06/30/26 - 4.81 03/31/26 - 5.20 12/31/25 - 5.53 Net Margin 06/30/26 - 4.81 03/31/26 - 5.20 12/31/25 - 5.53 Pre-Tax Margin 06/30/26 - 7.02 03/31/26 - 7.71 12/31/25 - 8.05 Book Value 06/30/26 - 3.83 03/31/26 - 3.80 12/31/25 - 3.78 Inventory Turnover 06/30/26 - 24.71 03/31/26 - 24.53 12/31/25 - 23.98 Debt-to-Equity 06/30/26 - 0.04 03/31/26 - 0.06 12/31/25 - 0.08 Debt-to-Capital 06/30/26 - 4.18 03/31/26 - 5.41 12/31/25 - 7.29

Powered by Zacks Investment Research ©